Novo Nordisk Obesity Care Strategy 2025 Commercial Execution

Novo Nordisk presents its obesity care strategy and commercial execution plan focused on delivering growth through innovation. The presentation outlines strategic aspirations including obesity sales target of over 25 billion DKK by 2025 and strengthening diabetes market leadership with a goal of capturing more than one-third global value market share.